AtaiBeckley (ATAI) Return on Sales (2021 - 2026)

AtaiBeckley's (ATAI) quarterly Return on Sales came in at 0.31% in Q1 2026, down 14.0% year-on-year from 0.36% in Q1 2025, and down 83.55% quarter-over-quarter from 0.17% in Q1 2025.

AtaiBeckley (ATAI) Return on Sales (2021 - 2026) Analysis & Trends

AtaiBeckley (ATAI) has 5 years of Return on Sales data on file, last reported at 0.82% in Q3 2025.

  • For the quarter ending Q3 2025, Return on Sales rose 585.0% year-over-year to 0.82%; the trailing twelve-month figure through Sep 2025 stood at 0.51% (up 336.0% YoY), and the FY2024 full-year result was 4.81%, down 352.0% from the prior year.
  • Return on Sales eased to 0.31% in Q1 2026 per ATAI's latest filing, from 0.17% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.17% in Q1 2025 and bottomed at 0.31% in Q1 2026.
  • A 5-year average of 4.9% and a median of 1.85% in 2023 frame the typical range for Return on Sales.
  • Across the five-year window, Return on Sales jumped 1886 bps in 2023 and tumbled 2208 bps in 2024, its largest moves.
  • Tracing ATAI's Return on Sales over 5 years: stood at 2.14% in 2021, then tumbled by 395 bps to 10.6% in 2022, then grew by 2 bps to 10.42% in 2023, then slumped by 212 bps to 32.49% in 2024, then jumped by 97 bps to 0.82% in 2025.
  • Business Quant data shows ATAI's Return on Sales at 0.82% in Q3 2025, 0.39% in Q2 2025, and 0.17% in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 0.00%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 0.00%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 0.00%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 0.00%
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 AtaiBeckley 2.56 Bn 2.56 Bn - -0.82%

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.31%
Sep 30, 2025 -0.82%
Jun 30, 2025 -0.39%
Mar 31, 2025 -0.17%
Mar 31, 2025 -0.17%
Dec 31, 2024 -32.49%
Sep 30, 2024 -6.67%
Jun 30, 2024 -2.09%
Mar 31, 2024 -1.18%
Dec 31, 2023 -10.42%
Sep 30, 2023 5.01%
Jun 30, 2023 -1.85%
Mar 31, 2023 -9.02%
Dec 31, 2022 -10.60%
Sep 30, 2022 -13.85%
Jun 30, 2022 -1.82%
Mar 31, 2022 -3.54%
Dec 31, 2021 -2.14%
Sep 30, 2021 -1.01%
Jun 30, 2021 -0.09%